These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10848757)

  • 21. Kaposiform hemangioendothelioma.
    Fernández Y; Bernabeu-Wittel M; García-Morillo JS
    Eur J Intern Med; 2009 Mar; 20(2):106-13. PubMed ID: 19327597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical approaches to the development of effective immunotherapeutic protocols for the treatment of metastasis.
    Talmadge JE
    Prog Clin Biol Res; 1986; 212():197-215. PubMed ID: 3520577
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of Stewart-Treves syndrome--treatment with recombinant interleukin 2 and a review of Japanese literature].
    Nabeya R; Kobayashi M; Fujita M; Yorifuji K; Eguchi N; Okamoto S
    Nihon Hifuka Gakkai Zasshi; 1990 Sep; 100(10):1029-39. PubMed ID: 2266596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of kaposiform hemangioendothelioma and tufted angioma.
    Liu XH; Li JY; Qu XH; Yan WL; Zhang L; Yang C; Zheng JW
    Int J Cancer; 2016 Oct; 139(7):1658-66. PubMed ID: 27252149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous angiosarcoma.
    Abrahamson TG; Stone MS; Piette WW
    Adv Dermatol; 2001; 17():279-99. PubMed ID: 11758119
    [No Abstract]   [Full Text] [Related]  

  • 27. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy?
    Bunn PA
    Arch Dermatol; 1995 May; 131(5):603-5. PubMed ID: 7537952
    [No Abstract]   [Full Text] [Related]  

  • 28. [Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].
    Korsaga-Somé N; Maruani A; Abdo I; Favrais G; Lorette G
    Ann Dermatol Venereol; 2015 Oct; 142(10):578-80. PubMed ID: 25999262
    [No Abstract]   [Full Text] [Related]  

  • 29. Relapse after successful treatment with immunotherapy: lessons for the future.
    Fisher RI
    Cancer J Sci Am; 1998; 4(2):78-9. PubMed ID: 9532407
    [No Abstract]   [Full Text] [Related]  

  • 30. [Spindle-cell hemangioendothelioma with monomelic and multifocal form in a child].
    Bodemer C; Fraitag S; Amoric JC; Benaceur S; Brunelle F; De Prost Y
    Ann Dermatol Venereol; 1997; 124(12):857-60. PubMed ID: 9732761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Denileukin diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell Lymphoma (mycosis fungoides): report of four cases.
    Buder K; Müller PA; Beckmann G; Ugurel S; Bröcker EB; Becker JC
    Acta Derm Venereol; 2014 Jan; 94(1):94-6. PubMed ID: 23756575
    [No Abstract]   [Full Text] [Related]  

  • 32. [Is interleukin 2 useful in oncology?].
    Négrier S
    Rev Prat; 1998 Feb; 48(3):237-9. PubMed ID: 9781067
    [No Abstract]   [Full Text] [Related]  

  • 33. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
    Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
    Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recombinant interleukin-2 (roncoleukin) in therapy of the patients with skin melanoma].
    Korovin SI; Tolstopiatov BA; Dovgopolaia OA; Palivets AIu
    Lik Sprava; 2005; (1-2):82-6. PubMed ID: 15916002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
    Ohguri T; Imada H; Nomoto S; Yahara K; Hisaoka M; Hashimoto H; Tokura Y; Nakamura K; Shioyama Y; Honda H; Terashima H; Moroi Y; Furue M; Korogi Y
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1446-53. PubMed ID: 15817349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2.
    Kawa-Ha K; Franco E; Doi S; Yumura K; Ishihara S; Tawa A; Yabuuchi H
    Lancet; 1987 Jan; 1(8525):154. PubMed ID: 2879982
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiotropic lymphoma: malignant angioendotheliomatosis.
    Helm TN; Bergfeld WF; Elston D
    Cutis; 1992 Sep; 50(3):204-6. PubMed ID: 1526176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-2 therapy proves durable in renal cell melanoma patients.
    Oncology (Williston Park); 1991 Sep; 5(9):71. PubMed ID: 1835879
    [No Abstract]   [Full Text] [Related]  

  • 39. Human recombinant interleukin-2 as an experimental therapeutic.
    Winkelhake JL; Gauny SS
    Pharmacol Rev; 1990 Mar; 42(1):1-28. PubMed ID: 2196590
    [No Abstract]   [Full Text] [Related]  

  • 40. Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangioperictyomas.
    Koch M; Nielsen GP; Yoon SS
    J Surg Oncol; 2008 Mar; 97(4):321-9. PubMed ID: 18286475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.